155 related articles for article (PubMed ID: 21511492)
1. Genomic analysis: toward a new approach in breast cancer management.
Cavallaro S; Paratore S; de Snoo F; Salomone E; Villari L; Buscarino C; Ferraù F; Banna G; Furci M; Strazzanti A; Cunsolo R; Pezzino S; Gangi S; Basile F
Crit Rev Oncol Hematol; 2012 Mar; 81(3):207-23. PubMed ID: 21511492
[TBL] [Abstract][Full Text] [Related]
2. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
3. Application of array-based genomic and epigenomic technologies to unraveling the heterogeneous nature of breast tumors: on the road to individualized treatment.
Abramovitz M; Leyland-Jones B
Cancer Genomics Proteomics; 2007; 4(3):135-45. PubMed ID: 17878517
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic signatures in breast cancer.
Fu J; Jeffrey SS
Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
[TBL] [Abstract][Full Text] [Related]
5. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
6. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer.
Tan DS; Reis-Filho JS
Pathobiology; 2008; 75(2):63-74. PubMed ID: 18544961
[TBL] [Abstract][Full Text] [Related]
8. [Histopathologic diagnosis of luminal and basal type breast cancer].
Sarcević B
Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
[TBL] [Abstract][Full Text] [Related]
9. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
Bertucci F; Viens P; Birnbaum D
Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
[TBL] [Abstract][Full Text] [Related]
10. State of the science: molecular classifications of breast cancer for clinical diagnostics.
Robison JE; Perreard L; Bernard PS
Clin Biochem; 2004 Jul; 37(7):572-8. PubMed ID: 15234238
[TBL] [Abstract][Full Text] [Related]
11. Review of gene-expression profiling and its clinical use in breast cancer.
Stadler ZK; Come SE
Crit Rev Oncol Hematol; 2009 Jan; 69(1):1-11. PubMed ID: 18614375
[TBL] [Abstract][Full Text] [Related]
12. [Has the time arrived for gene expression use at the bedside?].
D'Hondt V; Piccart M; Sotiriou C
Bull Cancer; 2008 Mar; 95(3):336-43. PubMed ID: 18390414
[TBL] [Abstract][Full Text] [Related]
13. [Breast carcinoma and genomic technology: contribution of DNA microarrays].
Sévenet N; Cottu PH
Bull Cancer; 2004 Dec; 91 Suppl 4():S226-31. PubMed ID: 15899613
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic implications of advances in breast cancer biology].
Bertucci F; Gonçalves A; Maraninchi D
Rev Prat; 2004 Apr; 54(8):865-70. PubMed ID: 15274460
[TBL] [Abstract][Full Text] [Related]
15. Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy.
Baehner FL; Lee M; Demeure MJ; Bussey KJ; Kiefer JA; Barrett MT
J Surg Oncol; 2011 May; 103(6):563-73. PubMed ID: 21480251
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers of breast axillary lymph node metastasis.
Cavalli LR
Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
[TBL] [Abstract][Full Text] [Related]
17. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.
Nuyten DS; van de Vijver MJ
Semin Radiat Oncol; 2008 Apr; 18(2):105-14. PubMed ID: 18314065
[TBL] [Abstract][Full Text] [Related]
18. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
19. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
[TBL] [Abstract][Full Text] [Related]
20. [Molecular alterations in breast cancer: clinical implications and new analytical tools].
Gonçalves A; Viens P; Sobol H; Maraninchi D; Bertucci F
Rev Med Interne; 2005 Jun; 26(6):470-8. PubMed ID: 15936476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
